Bronchiolitis Obliterans Syndrome
Immunology·MeSH: Bronchiolitis Obliterans Syndrome
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| itacitinib | Incyte Corp. (INCY) |
Frequently asked questions
How many drugs are in development for Bronchiolitis Obliterans Syndrome?
BioSniper tracks 1 drug in development for Bronchiolitis Obliterans Syndrome across 1 company.
How many clinical trials target Bronchiolitis Obliterans Syndrome?
There are 2 clinical trials targeting Bronchiolitis Obliterans Syndrome tracked by BioSniper.
Deep-dive into Bronchiolitis Obliterans Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis